Pediatric Grand Rounds

---

RSS

Occurs weekly every Monday starting on 1/1/2025 at 12:00 PM
Wednesday, January 1, 2025, 12:00 PM - 1:00 PM, Virtual, Houston, TX


AMA PRA Category 1 Credits™ (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

This series is targeted to clinicians in the field of Pediatrics. Clinicians will gain updates on the treatment, management and support of pediatric patients diagnosed with new or recurrent cancer of all types and other non-malignant disorders in certain cases, including sickle cell disease and other hemoglobinopathies and neurofibromatosis.

1. Identify cutting edge therapeutic options for pediatric cancer therapy.
2. Analyze diagnostic criteria and differential diagnosis for pediatric diseases.
3. Demonstrate appropriate testing for pediatric cancer patients.

If you are interested in attending this series, contact Ivette Rios at [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.